Skip to main content
OpenTrials

Clinical trial condition

Recurrent / Metastatic Head and Neck Squamous Cell Carcinoma

Explore clinical trials studying Recurrent / Metastatic Head and Neck Squamous Cell Carcinoma. Study availability and eligibility vary by location and protocol.

1 public trial 1 recruiting study
Refine in advanced search Browse all conditions

Recurrent / Metastatic Head and Neck Squamous Cell Carcinoma trial results

Recruiting

Study of Cetuximab Plus/Minus Weekly Paclitaxel After Progression To First-Line Pembrolizumab Plus Platinum-5FU in Subjects With Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck.

NCT06856213

Conditions
Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +6 more
Locations
  • Hospital Clínico Universitario de Santiago de Compostela Santiago de Compostela, A Coruña, Spain
  • Instituto Catalán de Oncología - Badalona Badalona, Barcelona, Spain
  • Instituto Catalán de Oncología - Hospital Duran i Reynals Barcelona, Spain
  • Hospital Universitario Marqués de Valdecilla (Santander) Santander, Cantabria, Spain
View all 17 locations
View Trial Details

Related conditions